Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product.

@article{Salot2007LargeSE,
  title={Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product.},
  author={Samuel Salot and Catherine Laplace and Soraya Sa{\"i}agh and Sylvain Bercegeay and Isabelle Tenaud and Alain Cassidanius and François Romagn{\'e} and Brigitte Dr{\'e}no and J{\'e}r{\^o}me Tiollier},
  journal={Journal of immunological methods},
  year={2007},
  volume={326 1-2},
  pages={63-75}
}
gamma9delta2 T lymphocytes are non-conventional lymphocytes presenting a direct cytotoxic effect against a broad range of tumour targets. These cells also secrete inflammatory cytokines that can boost the other components of the immune system. In contrast to conventional CD8(+) T cells, the cytotoxic effect of gamma9delta2 T lymphocytes does not depend on the expression of major histocompatibility complex molecules by target tumour cells. INNACELL gammadeltatrade mark is a cell therapy product… CONTINUE READING